Learn more about our out-licensing opportunities below. If you are interested in pursuing any of these opportunities, contact us here
For Asacol™, we are currently looking for distribution partners in certain countries in: CEE and LATAM markets as well as selected Asian countries.
Distribution or licensing rights for Colpermin™ are available for selected countries (North America and Europe: not including UK, Ireland and Switzerland).
We acquired Entocort™ in 2015 as a perfect fit for our geographic expansion strategy and to enhance our GI portfolio. It is Tillotts Pharma’s intention to realise the potential of Entocort™ and also to grow Entocort™ with active life-cycle programmes. We are currently looking for marketing partners in selected countries outside the USA and Japan.